Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010

Mahbubur Rahman, Tabassum H. Laz, Abbey Berenson

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Very little is known about geographic variation in human papillomavirus (HPV) vaccine uptake among young adult women in the US. To investigate this, we analyzed data from 12 US states collected through the Behavioral Risk Factor Surveillance System between 2008 and 2010. Among 2632 young adult women (18-26 years old) who responded to HPV vaccine uptake questions, weighted vaccine initiation and completion rates were: 28.0% and 17.0% overall, 14.0% and 6.6% in the South, 28.7% and 19.3% in the Midwest/West, and 37.2% and 23.1% in the Northeast (P< 0.001), respectively. Log-binomial regression analysis showed that women living in the South were less likely to initiate (adjusted prevalence ratio (aPR) 0.71, 95% confidence interval (CI) 0.60-0.83) or complete (aPR 0.61, 95% CI, 0.53-0.71) the HPV vaccine series compared to women living in the Northeast. Interventions programs to improve HPV vaccine uptake in the Southern states are warranted.

Original languageEnglish (US)
Pages (from-to)5495-5499
Number of pages5
JournalVaccine
Volume31
Issue number47
DOIs
StatePublished - Nov 12 2013

Fingerprint

Papillomavirus Vaccines
Papillomaviridae
young adults
geographical variation
Young Adult
Vaccination
vaccination
vaccines
Behavioral Risk Factor Surveillance System
Confidence Intervals
confidence interval
Vaccines
Regression Analysis
regression analysis
risk factors
monitoring

Keywords

  • BRFSS
  • Cervical cancer
  • Geographic variation
  • HPV vaccine
  • Human papillomavirus

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010. / Rahman, Mahbubur; Laz, Tabassum H.; Berenson, Abbey.

In: Vaccine, Vol. 31, No. 47, 12.11.2013, p. 5495-5499.

Research output: Contribution to journalArticle

@article{28f80fcc03a9486b900b44da0bc00069,
title = "Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010",
abstract = "Very little is known about geographic variation in human papillomavirus (HPV) vaccine uptake among young adult women in the US. To investigate this, we analyzed data from 12 US states collected through the Behavioral Risk Factor Surveillance System between 2008 and 2010. Among 2632 young adult women (18-26 years old) who responded to HPV vaccine uptake questions, weighted vaccine initiation and completion rates were: 28.0{\%} and 17.0{\%} overall, 14.0{\%} and 6.6{\%} in the South, 28.7{\%} and 19.3{\%} in the Midwest/West, and 37.2{\%} and 23.1{\%} in the Northeast (P< 0.001), respectively. Log-binomial regression analysis showed that women living in the South were less likely to initiate (adjusted prevalence ratio (aPR) 0.71, 95{\%} confidence interval (CI) 0.60-0.83) or complete (aPR 0.61, 95{\%} CI, 0.53-0.71) the HPV vaccine series compared to women living in the Northeast. Interventions programs to improve HPV vaccine uptake in the Southern states are warranted.",
keywords = "BRFSS, Cervical cancer, Geographic variation, HPV vaccine, Human papillomavirus",
author = "Mahbubur Rahman and Laz, {Tabassum H.} and Abbey Berenson",
year = "2013",
month = "11",
day = "12",
doi = "10.1016/j.vaccine.2013.09.022",
language = "English (US)",
volume = "31",
pages = "5495--5499",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "47",

}

TY - JOUR

T1 - Geographic variation in human papillomavirus vaccination uptake among young adult women in the United States during 2008-2010

AU - Rahman, Mahbubur

AU - Laz, Tabassum H.

AU - Berenson, Abbey

PY - 2013/11/12

Y1 - 2013/11/12

N2 - Very little is known about geographic variation in human papillomavirus (HPV) vaccine uptake among young adult women in the US. To investigate this, we analyzed data from 12 US states collected through the Behavioral Risk Factor Surveillance System between 2008 and 2010. Among 2632 young adult women (18-26 years old) who responded to HPV vaccine uptake questions, weighted vaccine initiation and completion rates were: 28.0% and 17.0% overall, 14.0% and 6.6% in the South, 28.7% and 19.3% in the Midwest/West, and 37.2% and 23.1% in the Northeast (P< 0.001), respectively. Log-binomial regression analysis showed that women living in the South were less likely to initiate (adjusted prevalence ratio (aPR) 0.71, 95% confidence interval (CI) 0.60-0.83) or complete (aPR 0.61, 95% CI, 0.53-0.71) the HPV vaccine series compared to women living in the Northeast. Interventions programs to improve HPV vaccine uptake in the Southern states are warranted.

AB - Very little is known about geographic variation in human papillomavirus (HPV) vaccine uptake among young adult women in the US. To investigate this, we analyzed data from 12 US states collected through the Behavioral Risk Factor Surveillance System between 2008 and 2010. Among 2632 young adult women (18-26 years old) who responded to HPV vaccine uptake questions, weighted vaccine initiation and completion rates were: 28.0% and 17.0% overall, 14.0% and 6.6% in the South, 28.7% and 19.3% in the Midwest/West, and 37.2% and 23.1% in the Northeast (P< 0.001), respectively. Log-binomial regression analysis showed that women living in the South were less likely to initiate (adjusted prevalence ratio (aPR) 0.71, 95% confidence interval (CI) 0.60-0.83) or complete (aPR 0.61, 95% CI, 0.53-0.71) the HPV vaccine series compared to women living in the Northeast. Interventions programs to improve HPV vaccine uptake in the Southern states are warranted.

KW - BRFSS

KW - Cervical cancer

KW - Geographic variation

KW - HPV vaccine

KW - Human papillomavirus

UR - http://www.scopus.com/inward/record.url?scp=84886771391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886771391&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2013.09.022

DO - 10.1016/j.vaccine.2013.09.022

M3 - Article

VL - 31

SP - 5495

EP - 5499

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 47

ER -